Precure Targeted Accrual and Rapid Growth in Enrollment Trial Study

Precure Targeted Accrual and Rapid Growth in Enrollment Trial (TARGET) Study

Status

Enrolling by invitation

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07756320

Acronym

TARGET

Enrollment

100000

Registered

2026-08-10

Start date

2026-08-07

Completion date

2035-12-01

Last updated

2026-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exposure, Environmental, Genetic Predisposition

Brief summary

The goal of this observational study is to 1) better understand and predict biological processes before disease begins or is identified, 2) study genomic and environmental contributors to disease, 3) identify ways to stop disease advancement before it becomes serious or complex, and 4) identify potential targets for disease therapy. Participants will be asked to: * collect biological samples

Interventions

None listed

Study design

Observational model

ECOLOGIC_OR_COMMUNITY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Age ≥ 18 years * Registered Mayo Clinic patient * Able to provide informed consent

Exclusion criteria

* Other co-morbidity that, in physician's opinion, would interfere with patient's ability to participate in the study

Design outcomes

Primary

Measure	Time frame
Number of participants (up to 100,000) who provide biospecimens and have associated environmental exposure and phenotypic data successfully linked and stored within the biorepository and research database for future research.	Up to 5 years

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORKonstantinos N. Lazaridis, M.D.

Mayo Clinic

Outcome results